# Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

> **NCT05932732** · PHASE4 · COMPLETED · sponsor: **Austin Institute for Clinical Research** · enrollment: 27 (actual)

## Conditions studied

- Cutis Laxa Facialis
- Xeroderma

## Interventions

- **DEVICE:** HydraFacial Syndeo System
- **DRUG:** ReGen-GF
- **DEVICE:** HydraFacial Elite MD System

## Key facts

- **NCT ID:** NCT05932732
- **Lead sponsor:** Austin Institute for Clinical Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-20
- **Primary completion:** 2024-10-09
- **Final completion:** 2024-10-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05932732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05932732, "Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05932732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*